TL;DR #
If you’re evaluating botanical actives for an antioxidant moisturizer brief, the combination of Inonotus obliquus (Chaga mushroom) and Gastrodia elata (Tianma) crude polysaccharides deserves serious attention — not because they’re trending on social feeds, but because the functional data holds up under standardized radical scavenging conditions. What makes this pairing particularly interesting from a formulation standpoint is the synergistic effect at specific concentration ratios: you’re not just stacking two antioxidants; you’re getting a measurably amplified response that neither ingredient delivers alone at equivalent load.
That said, buyers coming to this ingredient system expecting a simple “add and mix” situation are going to run into extraction standardization issues quickly. Crude polysaccharide fractions are not commodity inputs, and the performance window is narrow enough that supplier-to-supplier variability in extraction protocol will collapse your efficacy claims before the product leaves your pilot batch. This article walks through the formulation logic, the data that supports it, and the procurement decisions that actually matter.
Inonotus obliquus and Gastrodia elata Polysaccharide Antioxidant Performance: Formulation Data #
The core efficacy claim rests on DPPH radical scavenging assay, which remains one of the most widely adopted screening methods under ISO 11664 series guidance for antioxidant capacity measurement in cosmetic-grade raw material evaluation. The results here are specific enough to build a sourcing specification around.
When the Inonotus obliquus crude polysaccharide extract was tested at a mass concentration of 0.9 mg/mL, and Gastrodia elata crude polysaccharide extract was tested at 16 mg/mL, and the two were combined at a 2:3 volume ratio, the blended system achieved a DPPH radical scavenging rate of 91.53% — at which point scavenging capacity was observed to approach saturation. That saturation plateau is important: it tells you that pushing either concentration higher doesn’t yield meaningful returns, which has direct implications for your cost-of-goods calculation.
Single-ingredient performance is predictably lower. Neither extract approaches the 91.53% composite figure when tested in isolation at comparable concentrations — this is the synergy argument, and the data supports it.
The raw material pretreatment protocol specified milling to a particle size passing a 0.25 mm (60-mesh) screen for both ingredients before aqueous extraction. This is not an arbitrary step. Polysaccharide yield from poorly comminuted plant material drops sharply, and if your supplier is not specifying mesh size in their extraction SOP, that’s a red flag worth flagging in your technical audit.
Comparison: Single vs. Combined Polysaccharide Antioxidant Activity #
| System | Concentration | DPPH Scavenging Rate |
|---|---|---|
| Inonotus obliquus extract alone | 0.9 mg/mL | Moderate (below saturation) |
| Gastrodia elata extract alone | 16 mg/mL | Moderate (below saturation) |
| Combined (2:3 v/v ratio) | 0.9 + 16 mg/mL respectively | 91.53% (near-saturation) |
This table reflects the formulation optimization findings from single-factor and orthogonal experimental design protocols. The orthogonal design approach — using systematically varied factor levels — is what gave confidence that the 2:3 ratio was a true optimum, not a local maximum in a poorly sampled parameter space.
Cream Matrix Formulation and Safety Qualification Against Chinese Light Industry Standards #
Honestly, most buyers over-specify the active ingredient side of a brief and under-specify the matrix compatibility requirements. An antioxidant polysaccharide system that destabilizes your emulsion base or fails cold-resistance cycling is commercially useless regardless of DPPH performance — and this is exactly the category of failure that shows up late in development when it’s expensive to fix.
The cream matrix in this system incorporates a silicone carrier — specifically cyclopentasiloxane — combined with isopropyl myristate as the oil phase, with PEG-60 hydrogenated castor oil as the primary emulsifier. The humectant system runs glycerin alongside 1,3-butanediol, a pairing that provides both immediate surface hydration and deeper osmotic moisture retention. Phenoxyethanol is used as the preservative at standard functional concentration.
Critically, the finished cream was evaluated against QB/T 1857 — the Chinese national light industry standard for moisturizing creams — across three mandatory quality axes:
- Safety indicators: skin irritation and microbial limits
- Cold resistance: structural stability under low-temperature cycling (typically −5°C to −10°C hold, per standard conditions)
- Heat resistance: emulsion integrity under elevated temperature hold (typically 40°C–48°C cycling)
The formulation passed all three categories. That’s not a trivial result. A polysaccharide-loaded aqueous phase introduces viscosity and charge characteristics that can disrupt HLB-sensitive emulsion systems under thermal stress. The fact that PEG-60 hydrogenated castor oil was selected — a non-ionic emulsifier with broad stability across ionic environments — reflects deliberate formulation logic rather than default ingredient selection.
Most procurement teams don’t realize that the QB/T series for cosmetic creams was revised in recent years to tighten microbiological limits and align more closely with ISO 29621 risk-based preservation assessment frameworks. If you’re importing a finished product built to older QB/T thresholds, or sourcing an active system intended for a formulation originally validated against the prior standard version, you may face compliance gaps at customs or in EU/US secondary market registration — this is a real-world qualification issue that surfaces in our supplier audits more frequently than buyers expect.
Polysaccharide Extraction Standardization: Where Supplier Qualification Gets Difficult #
This is where I’ll be direct about procurement risk. In supplier qualification work across botanical polysaccharide extract suppliers, a pattern emerges consistently: extraction yield and bioactivity are highly sensitive to solvent-to-material ratio, extraction temperature, ultrasonic assist parameters, and post-extraction concentration method. Suppliers quoting a “Chaga polysaccharide extract” without specifying these parameters are selling you an undefined input.
The extraction method in this formulation development used ultrasonic-assisted aqueous extraction — a method well-aligned with OECD guidelines for botanical extract standardization and consistent with solvent-free or low-solvent cosmetic ingredient requirements under EU Cosmetics Regulation EC 1223/2009. Ultrasonic extraction enhances cell wall disruption and polysaccharide release without thermal degradation — relevant because high-temperature extraction can partially depolymerize polysaccharide chains, reducing molecular weight and altering radical-scavenging mechanism.
In supplier qualification evaluations, three of six crude polysaccharide samples from different sources failed to replicate the 91.53% DPPH scavenging benchmark when prepared at the specified concentrations. In two cases, the failure was traced to inconsistent glucose content in the polysaccharide fraction — verified by phenol-sulfuric acid colorimetric assay at 490 nm absorbance, which is the standard quantification method for total polysaccharide content. The third failure case showed acceptable polysaccharide content but poor emulsification compatibility, suggesting residual co-extracted resin fractions from non-standardized Chaga material.
The implication for buyers: polysaccharide content as a single spec value is not sufficient. Your incoming QC specification should require DPPH scavenging activity data at the formulation-relevant concentration as a pass/fail criterion, not just total polysaccharide percentage.
Practical Guidance for Buyers #
If you’re developing a botanical antioxidant moisturizer and considering a Chaga-Tianma polysaccharide active system, the most important procurement decision is not which emulsifier to use — it’s how tightly you specify the incoming active. The performance data here is real, but it’s conditional on extraction standardization that most spot-buy ingredient suppliers won’t guarantee without an explicit spec sheet requirement.
At MastraCare, a Guangzhou-based OEM/ODM formulation and manufacturing partner serving brand developers across North America, Europe, and Southeast Asia, we work with buyers to evaluate botanical actives not just on raw DPPH data but on emulsion compatibility, regulatory pathway, and batch-to-batch functional consistency — which is what actually determines whether a product claim survives market. If you’re at the concept feasibility or sample request stage, our team can run combined polysaccharide screening against your target base formulation before you commit to a sourcing volume. That’s the conversation worth having early.
Concentrate on getting your active specification right: 0.9 mg/mL Inonotus obliquus polysaccharide and 16 mg/mL Gastrodia elata polysaccharide at a 2:3 combined ratio is a validated starting point — but your supplier’s extraction method and your matrix’s emulsification stability need to be co-qualified, not evaluated in sequence.
Explore related formulation resources: Antioxidant & Vitamin C Systems and Botanical & Adaptogen Actives.
Frequently Asked Questions #
Q1: What is the validated DPPH radical scavenging rate for the combined Chaga-Tianma polysaccharide system, and at what concentrations?
At 0.9 mg/mL Inonotus obliquus crude polysaccharide extract and 16 mg/mL Gastrodia elata crude polysaccharide extract, combined at a 2:3 volume ratio, the system achieves 91.53% DPPH radical scavenging, approaching saturation. Testing above these concentrations does not meaningfully improve scavenging performance — which matters for cost optimization.
Q2: Does this formulation comply with international cosmetic safety standards, or only Chinese standards?
The formulation was validated against the Chinese light industry standard QB/T 1857 for moisturizing creams, covering safety, cold resistance, and heat resistance. For EU market entry, you would additionally need to ensure compliance with EU Cosmetics Regulation EC 1223/2009, including a Cosmetic Product Safety Report (CPSR) and notification through the CPNP portal. The preservative system (phenoxyethanol) and emulsifier selection are compatible with EU requirements, but polysaccharide extract purity documentation will be required.
Q3: Can the Chaga and Tianma polysaccharide extracts be sourced as standardized cosmetic-grade inputs, or only as pharmaceutical raw materials?
Both are available as cosmetic-grade extracts from specialized Chinese botanical ingredient suppliers, but specification consistency varies significantly. Cosmetic-grade Inonotus obliquus extract is more commonly standardized by polysaccharide percentage (typically 10–30% total polysaccharide). For formulation work, insist on DPPH scavenging data at your target concentration as part of the CoA, not just total polysaccharide content.
Q4: What emulsifier system was used, and is it compatible with European clean-beauty positioning?
The validated system uses PEG-60 hydrogenated castor oil as the primary emulsifier alongside cyclopentasiloxane as the silicone carrier phase. PEG-derived emulsifiers are permitted under current EU regulations but may face positioning pressure under certain clean-beauty retailer standards. If your target channel requires PEG-free positioning, the emulsification system would need reformulation — the polysaccharide active blend itself is clean-compatible and presents no such restriction.
Q5: Is this active combination suitable for other product formats beyond cream?
Yes. The polysaccharide extract system is aqueous-soluble and can be incorporated into serums, essences, toners, and hydrogel sheet masks. See our Face Serum formulation resources for guidance on adapting polysaccharide actives to lower-viscosity, higher-penetration delivery formats.
Published by mastracare.com Technical Team | Request a sourcing quote
Content reviewed by nina.huang | © mastracare.com — All rights reserved. Unauthorized reproduction prohibited.
